Your Location:
Home >
Browse articles >
Renshentang Alleviates Atherosclerosis in Mice by Targeting TRPV1 to Regulate Foam Cell Cholesterol Metabolism
Renshentang Alleviates Atherosclerosis in Mice by Targeting TRPV1 to Regulate Foam Cell Cholesterol Metabolism
- “The latest research found that Ginseng Decoction can regulate LXR/IDOL/LDLR signaling pathway by activating the expression of TRPV1, and effectively improve the lipid deposition and blood lipid level of atherosclerosis mice.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 17, Pages: 11-19(2025)
DOI: 10.13422/j.cnki.syfjx.20250903
Accepted:03 June 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 8 ) Tabs( 7 )
References
Publication Info
Metrics
351
Views
359
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanisms of Renshentang in Treating AS via Regulation of Endothelial Cell Inflammation Based on TRPV1
Effect of Huayu Qutan Recipe and its Separated Recipes on Cholesterol Metabolism in HepG2 Cells
Mechanism of Wendan Tang Against Atherosclerosis by Regulating Ferroptosis Based on JAK2/STAT3 Signaling Pathway
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway
Discussion on Modern Development of Traditional Chinese Medicine Diagnosis Based on Artificial Intelligence
Related Author
CHU Ce
YUAN Yulu
TAO Xuguang
HE Zhanzhan
ZHANG Yuxin
XU Yongqi
CHEN Wanping
WANG Wenlai
Related Institution
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
Lanxi Hospital of Traditional Chinese Medicine
Lanxi Traditional Chinese Medicine Hospital
West China Clinical Medical College, Sichuan University
Liaoning University of Traditional Chinese Medicine


